Atlas Trials

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Clinical trial NCT03024060 · WITHDRAWN

Trial details

NCT number
NCT03024060
Sponsor
DUSA Pharmaceuticals, Inc.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Actinic Keratosis
Start date
2017-03-01
Primary completion
2017-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.